Literature DB >> 11600473

Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function?

I Yasuda1, E Tomita, M Enya, T Kato, H Moriwaki.   

Abstract

BACKGROUND: Endoscopic papillary balloon dilation (EPBD) is assumed to preserve sphincter of Oddi function because it causes little trauma to the papilla. However, few studies have addressed this issue specifically. In this study, we investigated whether EPBD can preserve sphincter function, and evaluated whether or not such preservation has clinical significance.
METHODS: Seventy patients with common bile duct (CBD) stones were randomly assigned to EPBD or endoscopic sphincterotomy (EST). Sphincter of Oddi (SO) function was measured by endoscopic manometry before, one week after, and one year after treatment. Incidence of pneumobilia and later complications were compared between the two groups at one year. Series manometric data were compared within each group and between the two groups. For a more detailed analysis of the cumulative incidence of later complications, retrospective cohorts were added to the study groups, giving a total number of 235 patients in the EPBD group and 126 in the EST group.
RESULTS: Baseline characteristics did not differ significantly between the 35 EPBD and 35 EST patients. CBD stones were discharged successfully in all cases. CBD pressure, SO basal and peak pressures, and contraction frequency decreased significantly at one week in both groups. The damage was more severe in the EST group, and SO contraction completely disappeared in 23 patients in this group. The incidence of pneumobilia was significantly lower in the EPBD group than in the EST group (p<0.01) whereas CBD stones recurred and cholecystitis appeared at a similar rate in both groups at one year. A complete series of manometric data up to one year was obtained in 55 patients; 28 in the post-EPBD and 27 in post-EST groups. In the post-EPBD group, SO basal and peak pressures significantly recovered at one year compared with data at one week but these measures still remained significantly lower than those before EPBD (p< 0.01). In the post-EST group, SO contraction did not recover even after one year. A Kaplan-Meier analysis of 235 EPBD and 126 EST patients for a median follow up of 37 months revealed significantly lower incidences of biliary complications such as recurrent CBD stones and cholangitis, and cholecystitis in the EPBD group than in the EST group (p<0.05). The risk of pneumobilia was also significantly lower in the EPBD group (p<0.01).
CONCLUSIONS: Preservation of papillary function after EPBD was not complete but remained somewhat reduced. However, preservation was more successful with EPBD than with EST. Such preservation may be clinically beneficial for the prevention of later complications.

Entities:  

Mesh:

Year:  2001        PMID: 11600473      PMCID: PMC1728521          DOI: 10.1136/gut.49.5.686

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Endoscopic papillary balloon dilation in cirrhotic patients: removal of common bile duct stones without sphincterotomy.

Authors:  T Kawabe; Y Komatsu; M Tada; N Toda; M Ohashi; Y Shiratori; M Omata
Journal:  Endoscopy       Date:  1996-10       Impact factor: 10.093

2.  Endoscopic sphincterotomy: long-term results in 408 patients with complete follow-up.

Authors:  S Ikeda; M Tanaka; S Matsumoto; H Yoshimoto; H Itoh
Journal:  Endoscopy       Date:  1988-01       Impact factor: 10.093

3.  Papillary dilation vs sphincterotomy in endoscopic removal of bile duct stones. A randomized trial with manometric function.

Authors:  A Minami; T Nakatsu; N Uchida; S Hirabayashi; H Fukuma; S A Morshed; M Nishioka
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

4.  Endoscopic papillary dilation (EPD) for the treatment of common bile duct stones and papillary stenosis.

Authors:  M Staritz; K Ewe; K H Meyer zum Büschenfelde
Journal:  Endoscopy       Date:  1983-05       Impact factor: 10.093

5.  The acute and long-term effect of balloon sphincteroplasty on papillary structure in pigs.

Authors:  P Mac Mathuna; D Siegenberg; D Gibbons; D Gorin; M O'Brien; N A Afdhal; R Chuttani
Journal:  Gastrointest Endosc       Date:  1996-12       Impact factor: 9.427

6.  Removal of stones from the bile duct at ERCP without sphincterotomy.

Authors:  G R May; P B Cotton; S E Edmunds; W Chong
Journal:  Gastrointest Endosc       Date:  1993 Nov-Dec       Impact factor: 9.427

7.  Endoscopic sphincteroplasty: a novel and safe alternative to papillotomy in the management of bile duct stones.

Authors:  P Mac Mathuna; P White; E Clarke; J Lennon; J Crowe
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

8.  Long-term follow-up after endoscopic sphincterotomy (EST).

Authors:  E Seifert
Journal:  Endoscopy       Date:  1988-08       Impact factor: 10.093

9.  Long-term observations on morphological changes of choledochal epithelium after choledochoenterostomy in rats.

Authors:  K Kurumado; T Nagai; Y Kondo; H Abe
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

10.  Endoscopic balloon sphincteroplasty (papillary dilation) for bile duct stones: efficacy, safety, and follow-up in 100 patients.

Authors:  P M Mathuna; P White; E Clarke; R Merriman; J R Lennon; J Crowe
Journal:  Gastrointest Endosc       Date:  1995-11       Impact factor: 9.427

View more
  64 in total

1.  Cholecystectomy after endoscopic papillary balloon dilation for bile duct stones reduced late biliary complications: a propensity score-based cohort analysis.

Authors:  Yousuke Nakai; Hiroyuki Isayama; Takeshi Tsujino; Tsuyoshi Hamada; Hirofumi Kogure; Naminatsu Takahara; Dai Mohri; Saburo Matsubara; Natsuyo Yamamoto; Minoru Tada; Kazuhiko Koike
Journal:  Surg Endosc       Date:  2015-10-20       Impact factor: 4.584

Review 2.  Endoscopic papillary large balloon dilation for the removal of bile duct stones.

Authors:  Jin Hong Kim; Min Jae Yang; Jae Chul Hwang; Byung Moo Yoo
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

3.  Dilation-assisted stone extraction: an alternative method for removal of common bile duct stones.

Authors:  Guodong Li; Qiuping Pang; Xiujuan Zhang; Haiyan Dong; Rong Guo; Hailan Zhai; Yanchun Dong; Xinyong Jia
Journal:  Dig Dis Sci       Date:  2013-11-20       Impact factor: 3.199

4.  Laparoscopic exploration of the common bile duct with a rigid scope in patients with problematic choledocholithiasis.

Authors:  Ahmet Tekin; Zekai Ogetman
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

5.  Self-expandable metal stents for the extraction of common bile duct stones in patients receiving dual antiplatelet agents: a pilot study.

Authors:  Eunae Cho; Chang Hwan Park; Chung Hwan Jun; Hyun Soo Kim; Sung Kyu Choi; Jong Sun Rew
Journal:  Surg Endosc       Date:  2017-07-21       Impact factor: 4.584

6.  Ampulla dilation with different sized balloons to remove common bile duct stones.

Authors:  Neng-Ping Li; Jiang-Qi Liu; Zhi-Qiang Zhou; Tao-Ying Ji; Xiao-Yan Cai; Qing-Yun Zhu
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

7.  Prevention of pancreatitis after papillary balloon dilatation by nasobiliary drainage: a randomized controlled trial.

Authors:  Xiao-Dan Xu; Jian-Jun Dai; Jian-Qing Qian; Wei-Jun Wang
Journal:  Dig Dis Sci       Date:  2014-10-17       Impact factor: 3.199

Review 8.  Balloon dilation itself may not be a major determinant of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Sung Ill Jang; Gak Won Yun; Dong Ki Lee
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  Long-term prognosis after treatment of patients with choledocholithiasis.

Authors:  Kazuhisa Uchiyama; Hironobu Onishi; Masaji Tani; Hiroyuki Kinoshita; Manabu Kawai; Masaki Ueno; Hiroki Yamaue
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

10.  Endoscopic balloon dilatation versus endoscopic sphincterotomy for the removal of bile duct stones: a prospective randomised trial.

Authors:  P Vlavianos; K Chopra; S Mandalia; M Anderson; J Thompson; D Westaby
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.